Last reviewed · How we verify

Prednisolone acetate eye drops

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · FDA-approved active Small molecule

Prednisolone acetate eye drops is a Topical corticosteroid Small molecule drug developed by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. It is currently FDA-approved for Inflammation and pain following ocular surgery, Allergic conjunctivitis, Anterior uveitis.

Prednisolone acetate is a corticosteroid that suppresses local inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene production.

Prednisolone acetate is a corticosteroid that suppresses local inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene production. Used for Inflammation and pain following ocular surgery, Allergic conjunctivitis, Anterior uveitis.

At a glance

Generic namePrednisolone acetate eye drops
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Drug classTopical corticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaOphthalmology
PhaseFDA-approved

Mechanism of action

As a glucocorticoid, prednisolone acetate binds to cytoplasmic glucocorticoid receptors, translocates to the nucleus, and modulates gene expression to decrease inflammatory mediator synthesis and immune cell infiltration. When applied topically as eye drops, it achieves high local concentration in ocular tissues while minimizing systemic absorption, making it effective for treating anterior segment inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Prednisolone acetate eye drops

What is Prednisolone acetate eye drops?

Prednisolone acetate eye drops is a Topical corticosteroid drug developed by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, indicated for Inflammation and pain following ocular surgery, Allergic conjunctivitis, Anterior uveitis.

How does Prednisolone acetate eye drops work?

Prednisolone acetate is a corticosteroid that suppresses local inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene production.

What is Prednisolone acetate eye drops used for?

Prednisolone acetate eye drops is indicated for Inflammation and pain following ocular surgery, Allergic conjunctivitis, Anterior uveitis, Corneal injury, Steroid-responsive inflammatory conditions of the anterior segment.

Who makes Prednisolone acetate eye drops?

Prednisolone acetate eye drops is developed and marketed by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (see full Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine pipeline at /company/shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine).

What drug class is Prednisolone acetate eye drops in?

Prednisolone acetate eye drops belongs to the Topical corticosteroid class. See all Topical corticosteroid drugs at /class/topical-corticosteroid.

What development phase is Prednisolone acetate eye drops in?

Prednisolone acetate eye drops is FDA-approved (marketed).

What are the side effects of Prednisolone acetate eye drops?

Common side effects of Prednisolone acetate eye drops include Elevated intraocular pressure, Posterior subcapsular cataract formation, Local irritation or stinging, Delayed corneal wound healing, Secondary ocular infection.

What does Prednisolone acetate eye drops target?

Prednisolone acetate eye drops targets Glucocorticoid receptor and is a Topical corticosteroid.

Related